Molnupiravir

Molnupiravir

Molnupiravir (Lagevrio) is an antiviral drug that prevents specific RNA viruses from multiplying. It’s utilized to treat COVID-19 in people who have been infected with the SARS-CoV-2 virus. Molnupiravir is a pro – drug of the synthesized nucleoside derivative N4-hydroxycytidine that works against viruses by causing replicating errors during viral RNA synthesis. Molnupiravir was created at Emory University by Drug Innovation Ventures at Emory, the university’s drug development firm (DRIVE). EIDD-1931 was discovered when DRIVE …